| Literature DB >> 35328964 |
Alicja Naczk1, Tomasz Huzarski2, Janusz Doś1,3, Magdalena Górska-Doś1, Piotr Gramza4, Ewa Gajewska5, Mariusz Naczk6.
Abstract
The aim of the study was to evaluate the impact of inertial training on the muscle strength, on breast-cancer-related lymphedema, and on quality of life in breast cancer survivors. After a mastectomy, 24 women (age, 66.2 ± 10.6 years) were randomized to a training (n = 12) or control group (n = 12). The training group performed inertial training twice per week for 6 weeks with a training load of about 70% of the maximal force. Before and after training, we tested the maximum force of shoulder flexors, extensors, abductors, and adductors; body composition; breast-cancer-related lymphedema; and disabilities of the arm, shoulder, and hand. Inertial training significantly improved the strength in all tested muscles (from 32 to 68%; effect size (ES) from 0.89 to 1.85 in the impaired limb and from 31 to 64%; ES from 0.86 to 1.57 in the unimpaired limb). However, changes in the control group were not significant. Quality of life improved following treatment; the disabilities of the arm, shoulder, and hand score decreased significantly by 24.5% (ES from-0.29 to 1.38), p ≤ 0.05 in the training group and by 3.99% (ES from -0.49 to 1.14) in the control group p > 0.05. Breast-cancer-related lymphedema and body composition did not change significantly after the intervention in either group. We recommend inertial training for increasing muscle strength and improving quality of life in breast cancer survivors.Entities:
Keywords: breast cancer; inertial training; mastectomy; quality of life
Mesh:
Year: 2022 PMID: 35328964 PMCID: PMC8951502 DOI: 10.3390/ijerph19063278
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Subject positions during strength testing and training. The subjects’ positions (a) during flexion (first person) and during extension (second person); (b) during abduction (first person) and during adduction (second person). ROM—range of motion during flexion and extension (a) and during abduction and adduction (b).
Treatment applied in training group (T) and control group (C).
| Group | Simple Mastectomy | Breast-Conserving Surgery | Radiotherapy | Chemotherapy | Hormone | Lymphadenectomy |
|---|---|---|---|---|---|---|
| T | 7 | 5 | 7 | 6 | 9 | 8 |
| C | 9 | 3 | 7 | 8 | 7 | 9 |
Absolute values of strength (N), strength changes (%), and ES in tested shoulder muscles.
| Group/Muscle | Flexion | Extension | Abduction | Adduction | |||||
|---|---|---|---|---|---|---|---|---|---|
| N-IL | IL | N-IL | IL | N-IL | IL | N-IL | IL | ||
| T | Before | 34.85 ± 9.55 | 34.81 ± 8.56 | 38.33 ± 10.51 | 37.15 ± 11.97 | 31.67 ± 8.25 | 30.98 ± 6.90 | 30.57 ± 7.67 | 29.73 ± 8.36 |
| After | 43.50 ± 9.09 | 44.04 ± 10.69 | 53.04 ± 7.04 | 50.15 ± 10.61 | 41.82 ± 11.28 | 41.99 ± 12.37 | 47.81 ± 6.73 | 46.27 ± 8.28 | |
| % changes | 30.52 *, # | 31.92 *, # | 49.14 *, # | 46.96 *, # | 36.57 *, # | 38.86 *, # | 63.86 *, # | 68.06 *, # | |
| ES | 0.86 | 0.89 | 1.53 | 1.07 | 0.95 | 1.02 | 1.57 | 1.85 | |
| 95% CI | 0.02–1.80 | 0.04–1.83 | 0.57–2.67 | 0.20–2.06 | 0.10–1.91 | 0.16−2.00 | 0.60–2.72 | 0.82–3.11 | |
| C | Before | 30.07 ± 9.07 | 28.76 ± 6.65 | 32.63 ± 11.98 | 30.89 ± 8.69 | 26.60 ± 7.27 | 27.21 ± 6.19 | 27.72 ± 7.35 | 27.28 ± 6.81 |
| After | 29.27 ± 7.09 | 29.09 ± 7.09 | 31.15 ± 10.33 | 32.01 ± 8.35 | 27.49 ± 7.42 | 26.66 ± 8.29 | 27.59 ± 11.55 | 29.01 ± 9.75 | |
| % changes | 0.20 | 2.59 | −1.46 | 3.18 | 4.34 | −2.25 | −0.07 | 8.34 | |
| ES | −0.09 | 0.04 | −0.12 | 0.12 | 0.11 | −0.09 | −0.01 | −0.01 | |
| 95% CI | −0.90–0.70 | −0.85–0.75 | −0.93–0.67 | −0.67–0.93 | −0.68–0.92 | −0.86–0.71 | −0.81–0.79 | −1.00–0.60 | |
Notes: *—significant difference from baseline, #—significant difference from the control, (p ≤ 0.05). N-IL—non-impaired limb, IL—impaired limb.
Body composition changes following 6 weeks of intervention.
| Group/Muscle | Fat Mass (%) | Fat Mass (kg) | Total Body Water (kg) | Upper Limb Muscle Mass (kg) | |
|---|---|---|---|---|---|
| Before | 37.62 ± 4.78 | 28.59 ± 7.81 | 32.58 ± 4.00 | 4.36 ± 0.59 | |
| After | 37.98 ± 4.50 | 28.60 ± 7.79 | 32.13 ± 3.99 | 4.32 ± 0.59 | |
| T | % changes | 1.42 | 1.68 | −0.33 | −1.03 |
| ES | 0.07 | 0.00 | −0.1 | −0.06 | |
| 95% CI | −0.72–0.88 | −0.79–0.80 | −0.91–0.70 | −0.87–0.73 | |
| Before | 36.25 ± 2.48 | 25.72 ± 3.90 | 31.68 ± 3.07 | 4.58 ± 0.60 | |
| After | 36.88 ± 2.77 | 26.31 ± 3.59 | 31.71 ± 3.92 | 4.52 ± 0.59 | |
| C | % changes | 0.74 | −0.15 | −1.25 | −1.60 |
| ES | 0.22 | 0.14 | 0.01 | −0.09 | |
| 95% CI | −0.57–1.04 | −0.65–0.96 | −0.79–0.81 | −0.90–0.70 |